Ophthalmic market has growth in sight

Article

Philadelphia-In an uncertain economic climate, the ophthalmic market can take stock in knowing it is alive and well, according to Kenneth P. Taylor, an independent industry consultant.

Recent Videos
J. Peter Campbell, MD, MPH
Expanding accessibility of vision correction with spectacles for children with cranial abnormalities
Elkin: Talking about the importance of pediatric eye health and safety
Identifying 3 barriers keeping families from accessing cataract treatment for their children in India
John Saharek, president of ImprimisRX, speaks with Ophthalmology Times' David Hutton on three new products the company will be featuring during the American Academy of Ophthalmology's 2021 annual meeting
Edward Manche, MD
Related Content
Data demonstrates efficacy of FDA-approved therapy for treating amblyopia in children

Data demonstrates efficacy of FDA-approved therapy for treating amblyopia in children

Article
ROP: Treating and preventing blindness in preterm babies

ROP: Treating and preventing blindness in preterm babies

Podcast
Vyluma meets with FDA to discuss atropine sulfate ophthalmic solution 0.01% for the treatment of pediatric myopia

Vyluma meets with FDA to discuss atropine sulfate ophthalmic solution 0.01% for the treatment of pediatric myopia

Article
Managing a changing landscape of IRD pediatric cases

Managing a changing landscape of IRD pediatric cases

Podcast
Dopavision reports positive results from MyopiaX-1 trial on pediatric myopia management

Dopavision reports positive results from MyopiaX-1 trial on pediatric myopia management

Article
Bipartisan proposal introduced in US House to address children's vision impairment

Bipartisan proposal introduced in US House to address children's vision impairment

Article
© 2024 MJH Life Sciences

All rights reserved.